Annual Drug Patent Expirations for MYDAYIS Mydayis is a drug marketed by Shire Dev Llc and is included in one NDA. It is available from one supplier. There are five…
Posts published in “Patent Expiration”
Annual Drug Patent Expirations for EXTINA Extina is a drug marketed by Mylan Pharms Inc and is included in one NDA. It is available from two suppliers. There are two…
EXTINA (ketoconazole) Mylan pharms inc Patent: 8,026,238 Expiration: Oct 19, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…
Annual Drug Patent Expirations for VIMOVO Vimovo is a drug marketed by Horizon and is included in one NDA. It is available from one supplier. There are fourteen patents protecting…
Annual Drug Patent Expirations for GILOTRIF Gilotrif is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
Annual Drug Patent Expirations for LETAIRIS Letairis is a drug marketed by Gilead and is included in one NDA. It is available from one supplier. There are four patents protecting…
SPIRIVA (tiotropium bromide) Boehringer ingelheim Patent: RE39820 Expiration: Jul 30, 2018 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com…
Annual Drug Patent Expirations for RAVICTI Ravicti is a drug marketed by Horizon Theraps Inc and is included in one NDA. It is available from one supplier. There are eight…
Annual Drug Patent Expirations for VIADUR Viadur is a drug marketed by Ortho Mcneil Janssen and is included in one NDA. There are two patents protecting this drug. Drug patent…
Annual Drug Patent Expirations for XERESE Xerese is a drug marketed by Valeant Bermuda and is included in one NDA. It is available from one supplier. There are two patents…